Understanding Pain Pathways and Management Strategies in Peripheral Artery Disease
Test your knowledge of the multifactorial nature of pain in PAD and best practices for multimodal pain management.
Related Articles
FDA Approves Pembrolizumab for Adults with Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma
The FDA announced on June 12 that it has approved pembrolizumab for adult patients with resectable locally advanced head and neck squamous cell carcinoma (HNSCC)…
Hiatal Hernia Repair After RYGB Improves Refractory Reflux Symptoms
Presented at the 2025 American Society for Metabolic and Bariatric Surgery Annual Meeting, June 15-19 in Washington, D.C., this study examined symptom outcomes following hiatal…
Tolebrutinib Reduces Disability Progression in Nonrelapsing Secondary Progressive Multiple Sclerosis
In a phase 3 trial, tolebrutinib, an oral Bruton’s tyrosine kinase inhibitor, significantly reduced the risk of sustained disability progression in patients with nonrelapsing secondary…
Choosing the Right Image: Tailoring Interventional Pain Procedures to the Patient
In his presentation at the American Academy of Pain Medicine PainConnect 2025 annual meeting in Austin, TX, Scott Pritzlaff, MD, reviewed how modalities like MRI,…
Robotic Surgery Lowers Locoregional Recurrence and Improves Functional Outcomes in Middle and Low Rectal Cancer
Robotic surgery significantly reduced the 3-year locoregional recurrence rate and improved disease-free survival in patients with middle or low rectal cancer compared with conventional laparoscopic…
Oral Semaglutide Reduces Cardiovascular Events for High-Risk Patients With Type 2 Diabetes
For patients with type 2 diabetes and established cardiovascular or kidney disease, daily oral semaglutide significantly lowered the risk of major adverse cardiovascular events during…
County-Level Trends Reveal Declining MMR Vaccination Coverage Across the US Post-Pandemic
A national analysis of county-level measles-mumps-rubella vaccination rates from 2017 to 2024 shows a significant decline following the COVID-19 pandemic, with geographic variation and implications…
Call for Papers and Reviewers
Want to Peer Review for Consultant? We would welcome your involvement! Please send a short email to the editorial office summarizing your areas of expertise and qualifications to our…
As-Needed Albuterol–Budesonide in Mild Asthma
A phase 3b trial evaluated as-needed albuterol–budesonide versus albuterol alone in patients with uncontrolled mild asthma.